Medical Device Investing ChroMedX Reports on HemoPalm Techno-Commercial Analysis and Productization Plan
Medical Device Investing ChroMedX CEO Lahav Gil Invited to Speak on Industry Panel at bioTEC, Biotechnology and Bioengineering Conference
Medical Device Investing ChroMedX Accelerates Software Development and Implementation Activities; Appoints iGAL Roytblat, Formerly of Kangaroo Group, as CTO, Amid Expansion
Medical Device Investing ChroMedX Appoints Raj Kailasanathan as Executive Vice President Corporate Finance
